|
|
Blood, 15 November 2004, Vol. 104, No. 10, pp. 3126-3135.
Prepublished online as a Blood First Edition Paper on July 22, 2004; DOI 10.1182/blood-2003-07-2597.
 Previous Article | Table of Contents | Next Article 
HEMATOPOIESIS
Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells
Elena Tenedini,
Maria Elena Fagioli,
Nicola Vianelli,
Pier Luigi Tazzari,
Francesca Ricci,
Enrico Tagliafico,
Paolo Ricci,
Luigi Gugliotta,
Giovanni Martinelli,
Sante Tura,
Michele Baccarani,
Sergio Ferrari, and
Lucia Catani
From the Istituto di Ematologia e Oncologia Medica "L. e A. Seràgnoli," Università di Bologna, Bologna, Italy; Servizio di Medicina Trasfusionale, Ospedale S. Orsola, Bologna; Dipartimento di Scienze Biomediche, Sezione di Chimica Biologica, Università di Modena e Reggio Emilia, Modena; and Arcispedale "S. Maria Nuova," Unità Operativa Ematologia, Reggio Emilia, Italy.
Gene expression profiles of bone marrow (BM) CD34-derived megakaryocytic cells (MKs) were compared in patients with essential thrombocythemia (ET) and healthy subjects using oligonucleotide microarray analysis to identify differentially expressed genes and disease-specific transcripts. We found that proapoptotic genes such as BAX, BNIP3, and BNIP3L were down-regulated in ET MKs together with genes that are components of the mitochondrial permeability transition pore complex, a system with a pivotal role in apoptosis. Conversely, antiapoptotic genes such as IGF1-R and CFLAR were up-regulated in the malignant cells, as was the SDF1 gene, which favors cell survival. On the basis of the array results, we characterized apoptosis of normal and ET MKs by time-course evaluation of annexin-V and sub-G1 peak DNA stainings of immature and mature MKs after culture in serum-free medium with an optimal thrombopoietin concentration, and annexin-V–positive MKs only, with decreasing thrombopoietin concentrations. ET MKs were more resistant to apoptosis than their normal counterparts. We conclude that imbalance between proliferation and apoptosis seems to be an important step in malignant ET megakaryocytopoiesis.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
T. I. Fortoul, A. Gonzalez-Villalva, G. Pinon-Zarate, V. Rodriguez-Lara, L. F. Montano, and L. Saldivar-Osorio
Ultrastructural megakaryocyte modifications after vanadium inhalation in spleen and bone marrow
J. Electron Microsc. (Tokyo),
December 1, 2009;
58(6):
375 - 380.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A M Florena, C Tripodo, A Di Bernardo, E Iannitto, C Guarnotta, R Porcasi, S Ingrao, V Abbadessa, and V Franco
Different immunophenotypical apoptotic profiles characterise megakaryocytes of essential thrombocythaemia and primary myelofibrosis
J. Clin. Pathol.,
April 1, 2009;
62(4):
331 - 338.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Gozgit, G. Bebernitz, P. Patil, M. Ye, J. Parmentier, J. Wu, N. Su, T. Wang, S. Ioannidis, A. Davies, et al.
Effects of the JAK2 Inhibitor, AZ960, on Pim/BAD/BCL-xL Survival Signaling in the Human JAK2 V617F Cell Line SET-2
J. Biol. Chem.,
November 21, 2008;
283(47):
32334 - 32343.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Gemelli, C. Orlandi, T. Z. Marani, A. Martello, T. Vignudelli, F. Ferrari, M. Montanari, S. Parenti, A. Testa, A. Grande, et al.
The Vitamin D3/Hox-A10 Pathway Supports MafB Function during the Monocyte Differentiation of Human CD34+ Hemopoietic Progenitors
J. Immunol.,
October 15, 2008;
181(8):
5660 - 5672.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. O. Ciurea, D. Merchant, N. Mahmud, T. Ishii, Y. Zhao, W. Hu, E. Bruno, G. Barosi, M. Xu, and R. Hoffman
Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis
Blood,
August 1, 2007;
110(3):
986 - 993.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. C. Macaulay, M. R. Tijssen, D. C. Thijssen-Timmer, A. Gusnanto, M. Steward, P. Burns, C. F. Langford, P. D. Ellis, F. Dudbridge, J.-J. Zwaginga, et al.
Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins
Blood,
April 15, 2007;
109(8):
3260 - 3269.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Chen, M. Hu, and R. A. Shivdasani
Expression analysis of primary mouse megakaryocyte differentiation and its application in identifying stage-specific molecular markers and a novel transcriptional target of NF-E2
Blood,
February 15, 2007;
109(4):
1451 - 1459.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. V. Gnatenko, P. L. Perrotta, and W. F. Bahou
Proteomic approaches to dissect platelet function: half the story
Blood,
December 15, 2006;
108(13):
3983 - 3991.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
